Diphenylpyraline is an antihistamine. Antihistamines used in the treatment of allergy act by competing with histamine for H 1-receptor sites on effector cells. Antihistamines prevent, but do not reverse, responses mediated by histamine alone. Antihistamines antagonize, in varying degrees, most of the pharmacological effects of histamine, including urticaria and pruritus.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Benzylpenicilloyl polylysine | Diphenylpyraline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent. |
| Betahistine | The therapeutic efficacy of Betahistine can be decreased when used in combination with Diphenylpyraline. |
| Amphetamine | Amphetamine may decrease the sedative activities of Diphenylpyraline. |
| Phentermine | Phentermine may decrease the sedative activities of Diphenylpyraline. |
| Pseudoephedrine | Pseudoephedrine may decrease the sedative activities of Diphenylpyraline. |
| Benzphetamine | Benzphetamine may decrease the sedative activities of Diphenylpyraline. |
| Diethylpropion | Diethylpropion may decrease the sedative activities of Diphenylpyraline. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the sedative activities of Diphenylpyraline. |
| Mephentermine | Mephentermine may decrease the sedative activities of Diphenylpyraline. |
| MMDA | MMDA may decrease the sedative activities of Diphenylpyraline. |
| Midomafetamine | Midomafetamine may decrease the sedative activities of Diphenylpyraline. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative activities of Diphenylpyraline. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative activities of Diphenylpyraline. |
| Tenamfetamine | Tenamfetamine may decrease the sedative activities of Diphenylpyraline. |
| Chlorphentermine | Chlorphentermine may decrease the sedative activities of Diphenylpyraline. |
| Methylenedioxyethamphetamine | Methylenedioxyethamphetamine may decrease the sedative activities of Diphenylpyraline. |
| Dextroamphetamine | Dextroamphetamine may decrease the sedative activities of Diphenylpyraline. |
| Metamfetamine | Metamfetamine may decrease the sedative activities of Diphenylpyraline. |
| Iofetamine I-123 | Iofetamine I-123 may decrease the sedative activities of Diphenylpyraline. |
| Ritobegron | Ritobegron may decrease the sedative activities of Diphenylpyraline. |
| Mephedrone | Mephedrone may decrease the sedative activities of Diphenylpyraline. |
| Methoxyphenamine | Methoxyphenamine may decrease the sedative activities of Diphenylpyraline. |
| Gepefrine | Gepefrine may decrease the sedative activities of Diphenylpyraline. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | 2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative activities of Diphenylpyraline. |
| Phendimetrazine | Phendimetrazine may decrease the sedative activities of Diphenylpyraline. |
| Pitolisant | The therapeutic efficacy of Pitolisant can be decreased when used in combination with Diphenylpyraline. |
| Norepinephrine | The therapeutic efficacy of Norepinephrine can be increased when used in combination with Diphenylpyraline. |
| Epinephrine | The therapeutic efficacy of Epinephrine can be increased when used in combination with Diphenylpyraline. |
| Droxidopa | The therapeutic efficacy of Droxidopa can be increased when used in combination with Diphenylpyraline. |
| Levonordefrin | The therapeutic efficacy of Levonordefrin can be increased when used in combination with Diphenylpyraline. |
| Protokylol | The therapeutic efficacy of Protokylol can be increased when used in combination with Diphenylpyraline. |
| Racepinephrine | The therapeutic efficacy of Racepinephrine can be increased when used in combination with Diphenylpyraline. |
| Theodrenaline | The therapeutic efficacy of Theodrenaline can be increased when used in combination with Diphenylpyraline. |
| Deoxyepinephrine | The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Diphenylpyraline. |
| Ephedrine | The therapeutic efficacy of Ephedrine can be increased when used in combination with Diphenylpyraline. |
| Hyoscyamine | Diphenylpyraline may increase the anticholinergic activities of Hyoscyamine. |